HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jacob Zeitani Selected Research

Jacob Zeitani Research Topics

Disease

2Rupture
04/2020 - 10/2013
2Aortic Dissection
09/2007 - 03/2006
1Mitral Valve Insufficiency (Mitral Regurgitation)
12/2022
1Inflammation (Inflammations)
01/2022
1Acidosis
04/2020
1Thoracoabdominal Aortic Aneurysm
04/2020
1Carotid Artery Diseases
04/2015
1Coronary Artery Disease (Coronary Atherosclerosis)
04/2015
1Aortic Arch Aneurysm
10/2013
1Aortic Valve Disease
08/2013
1Atrial Fibrillation
08/2013
1Endocarditis
07/2011
1Death (Near-Death Experience)
07/2011
1Thromboembolism
07/2011
1Bone Fractures (Bone Fracture)
01/2008
1Transient Ischemic Attack
11/2007
1Hemorrhage
11/2007
1Myocardial Infarction
11/2007
1Stroke (Strokes)
11/2007
1False Aneurysm (Pseudoaneurysm)
03/2006
1Unstable Angina
03/2006
1High Cardiac Output
06/2005
1Surgical Wound Dehiscence
02/2004
1Mediastinitis
02/2004
1Wound Infection (Wound Infections)
02/2004
1Wounds and Injuries (Trauma)
02/2004

Drug/Important Bio-Agent (IBA)

11,1'- (4,4,7,7- tetramethyl- 4,7- diazaundecamethylene)bis- 4- (3- methyl- 2,3- dihydro(benzo- 1,3- thiazole)- 2- methylidene)quinolinium (TOTO)IBA
10/2013
1Dihydrotachysterol (AT 10)IBA
07/2011

Therapy/Procedure

3Prostheses and Implants (Prosthesis)
04/2020 - 06/2005
3Sternotomy
10/2013 - 02/2004
1Myocardial Revascularization
12/2022
1Euthanasia (Mercy Killing)
01/2022
1Surgical Anastomosis
04/2020
1Prosthesis Implantation
04/2020
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
04/2015
1Therapeutics
08/2013
1Maze Procedure
08/2013
1Aftercare (After-Treatment)
11/2007
1Emergency Treatment
09/2007
1Replantation
09/2007
1Sutures (Suture)
03/2006
1Debridement
02/2004
1Contraindications
02/2004